| Mutational analysis of the H-ras oncogene in spontaneous C57BL/6 x C3H/He mouse liver tumors and tumors induced with genotoxic and nongenotoxic hepatocarcinogens. | liver, |
| [Molecular nature of oncogene HRAS1 damage in human breast carcinoma: G----T transversion in codon 12 of one allele during deletion of other allele]. | breast, |
| No acquisition of metastatic capacity of R1H rhabdomyosarcoma upon transfection with c-Ha-ras oncogene. | sarcoma, |
| BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study. | colorectal, |
| [Chromosomal localization of transforming oncogene BGC-Ha-ras in gastric cancer cell line]. | gastric, |
| Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1. | skin, |
| K-Ras and B-Raf oncogenes inhibit colon epithelial polarity establishment through up-regulation of c-myc. | colorectal, |
| Neoplastic transformation of a human kidney epithelial cell line transfected with v-Ha-ras oncogene. | kidney, |
| Results suggest that mosaicism for oncogenic HRAS mutations may increase the risk for developing bladder cancer at a young age. | bladder, |
| Comparative study of Harvey-ras oncogene expression with conventional clinicopathologic parameters of breast cancer. | breast, |
| H-ras oncogene expression and angiogenesis in experimental liver cirrhosis. | liver, |
| A sensitive non-radioactive PCR-RFLP analysis for detecting point mutations at 12th codon of oncogene c-Ha-ras in DNAs of gastric cancer. | gastric, |
| Uniparental Trisomy of a Mutated HRAS Proto-Oncogene in Embryonal Rhabdomyosarcoma of a Patient With Costello Syndrome. | sarcoma, |
| Ras(V12)-mediated oncogenic transformation induces RRAD epigenetic inactivation, which in turn promotes glucose uptake and may contribute to ovarian cancer | ovarian, |
| Oncogenic HRAS in head and neck squamous cell cancer promotes activation of ERK signaling, which in turn mediates cetuximab resistance | HNSC, |
| Transformation of human kidney epithelial cells to tumorigenicity by nickel(II) and V-HA-RAS oncogene. | kidney, |
| Urokinase-type plasminogen activator biosynthesis is induced by the EJ-Ha-ras oncogene in CL26 mouse colon carcinoma cells. | colorectal, |
| Oncogene-induced liver neoplasia in transgenic mice. | liver, |
| Insertion of the v-Ha-ras oncogene induces differentiation of calcitonin-producing human small cell lung cancer. | lung, |
| Detection of the H-RAS oncogene in human thyroid anaplastic carcinomas. | thyroid, |